Cardinal Health to Buy J&J’s Heart Business

Cardinal Health Inc. has concluded to buy a heart-product business of Johnson Johnson for $1.94 billion in cash, in a pierce that will supplement stents and catheters to a list of products Cardinal offers to hospitals, physicians and ambulatory centers.

When including taxation benefits, Cardinal’s squeeze cost for Cordis drops to $1.59 billion.

About admin